The effect of 2 different single injections of high dose of vitamin D on improving the depression in depressed patients with vitamin D deficiency: A randomized clinical trial

Journal of Clinical Psychopharmacology

Volumn 33, Issue 3, 2013, Pages 378-385

  Mozaffari Khosravi, Hassan ^a   Nabizade, Lale ^a   Yassini Ardakani, Seyed Mojtaba ^b   Hadinedoushan, Hossein ^a   Barzegar, Kazem ^a  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Department of Clinical Sciences Faculty of Medicine   (Iran)

Author keywords

depression; vitamin D; vitamin D deficiency

Indexed keywords

CALCIUM; PHOSPHORUS; VITAMIN D;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; CALCIUM; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; IRAN; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS; YOUNG ADULT;

EID: 84877581012     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31828f619a     Document Type: Article

References (52)

1. Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status. J Nutr. 2005; 135: 310-316.
2. Gallagher ML. The nutrients and their metabolism. In: Mahan L, Escott-Stump S, eds. Krause' s Food and Nutrition Therapy. 12th ed. Philadelphia, PA: W.B. Saunders Company; 2008: 74-78.
3. Tangpricha V, Pearce EN, Chen TC, et al. Vitamin D insufficiency among free-living healthy young adults. Am J Med. 2002; 112: 659-662.
4. Lips P, Duong T, Oleksik A, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab. 2001; 86: 1212-1221.
5. Gannage-Yared MH, Chemali R, Yaacoub N, et al. Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers. J Bone Miner Res. 2000; 15: 1856-1862.
6. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004; 80: 1678SY1688S.
7. Hashemipour S, Larijani B, Adibi H, et al. Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health. 2004; 4: 38-44.
8. Shakiba M, Nafei Z, Lotfi MH, et al. Prevalence of vitamin D deficiency among female students in secondary guidance school in Yazd City. Acta Medica Iranica. 2009; 47: 209-214.
9. Mozaffari-Khosravi H, Hosseinzadeh-Shamsi-Anar M, Salami MA, et al. Effects of a single postpartum injection of a high dose of vitamin D on glucose tolerance and insulin resistance in mothers with first-time gestational diabetes mellitus. Diabet Med. 2012; 29: 36-42.
10. Chiu KC, Chu A, Go VL, et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004; 79: 820-825.
11. Danescu LG, Levy S, Levy J. Vitamin D and diabetes mellitus. Endocrine. 2009; 35: 11-17.
12. Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension. 2008; 52: 828-832.
13. Luong KV, Nguyen LT. Vitamin D and cardiovascular disease. Curr Med Chem. 2006; 13: 2443-2447.
14. Achinger SG, Ayus JC. The role of vitamin D in left ventricular hypertrophy and cardiac function. Kidney Int Suppl. 2005; 95: S37YS42.
15. Garland CF, Grant WB, Mohr SB, et al. What is the dose-response relationship between vitamin D and cancer risk? Nutr Rev. 2007; 65: S91YS95.
16. Oudshoorn C, Mattace-Raso FU, van d V, et al. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord. 2008; 25: 539-543.
17. Kalueff AV, Minasyan A, Keisala T, et al. The vitamin D neuroendocrine system as a target for novel neurotrophic drugs. CNS Neurol Disord Drug Targets. 2006; 5: 363-371.
18. McCann JC, Ames BN. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J. 2008; 22: 982-1001.
19. Garcion E, Wion-Barbot N, Montero-Menei CN, et al. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002; 13: 100-105.
20. Eyles DW, Smith S, Kinobe R, et al. Distribution of the vitamin D receptor and 1 alphahydroxylase in human brain. J Chem Neuroanat. 2005; 29: 21-30.
21. Lewis-Fernandez R, Das AK, Alfonso C, et al. Depression in US Hispanics: diagnostic and management considerations in family practice. J Am Board Fam Pract. 2005; 18: 282-296.
22. Stewart DE, Rondon M, Damiani G, et al. International psychosocial and systemic issues in women mental health. Arch Women's Mental Health. 2001; 4: 13-17.
23. Wada T, Ishine M, Sakagami T, et al. Depression, activities of daily living, and quality of life of community-dwelling elderly in three Asian countries: Indonesia, Vietnam, and Japan. Arch Gerontol Geriatr. 2005; 41: 271-280.
24. Sadeghirad B, Haghdoost AA, min-Esmaeili M, et al. Epidemiology of major depressive disorder in Iran: a systematic review and meta-analysis. Int J Prev Med. 2010; 1: 81-91.
25. Belmaker RH, Agam G. Major depressive disorder. N Engl J Med. 2008; 358: 55-68.
26. Frazer CJ, Christensen H, Griffiths KM. Effectiveness of treatments for depression in older people. Med J Aust. 2005; 182: 627-632.
27. Bodnar LM, Wisner KL. Nutrition and depression: implications for improving mental health among childbearing-aged women. Biol Psychiatry. 2005; 58: 679-685.
28. Murphy PK, Wagner CL. Vitamin D and mood disorders among women: an integrative review. J Midwifery Womens Health. 2008; 53: 440-446.
29. Parker G, Brotchie H. 'D' for depression: any role for vitamin D? 'Food for thought' II. Acta Psychiatr Scand. 2011; 124: 243-249.
30. Bertone-Johnson ER. Vitamin D and the occurrence of depression: causal association or circumstantial evidence? Nutr Rev. 2009; 67: 481-492.
31. Humble MB. Vitamin D, light and mental health. J Photochem Photobiol B. 2010; 101: 142-149.
32. Wilkins CH, Sheline YI, Roe CM, et al. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry. 2006; 14: 1032-1040.
33. Przybelski RJ, Binkley NC. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys. 2007; 460: 202-205.
34. Zhao G, Ford ES, Li C, et al. No associations between serum concentrations of 25-hydroxyvitamin D and parathyroid hormone and depression among US adults. Br J Nutr. 2010; 104: 1696-1702.
35. Jorde R, Waterloo K, Saleh F, et al. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromso study. J Neurol. 2006; 253: 464-470.
36. Jorde R, Sneve M, Figenschau Y, et al. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med. 2008; 264: 599-609.
37. Schneider B, Weber B, Frensch A, et al. Vitamin D in schizophrenia, major depression and alcoholism. J Neural Transm. 2000; 107: 839-842.
38. Hoogendijk WJ, Lips P, Dik MG, et al. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry. 2008; 65: 508-512.
39. Milaneschi Y, Shardell M, Corsi AM, et al. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J Clin Endocrinol Metab. 2010; 95: 3225-3233.
40. Ganji V, Milone C, Cody MM, et al. Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey. Int Arch Med. 2010; 3: 29-37.
41. Prufer K, Veenstra TD, Jirikowski GF, et al. Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. J Chem Neuroanat. 1999; 16: 135-145.
42. Ghassemzadeh H, Mojtabai R, Karamghadiri N, et al. Psychometric properties of a Persian language version of the Beck Depression InventoryVsecond edition: BDI-II-PERSIAN. Depress Anxiety. 2005; 21: 185-192.
43. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory Y II. The Psychological Corporation. San Antonio, TX: Harcourt Brace & Company; 1996.
44. Moradzadeh K, Larijani B, Keshtkar AA, et al. Normative Values of Vitamin D Among Iranian Population: A Population-Based Study. 1 ed 2008: 8-15.
45. Pan A, Lu L, Franco OH, et al. Association between depressive symptoms and 25-hydroxyvitamin D in middle-aged and elderly Chinese. J Affect Disord. 2009; 118: 240-243.
46. Vieth R, Kimball S, Hu A, et al. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J. 2004; 3: 81.
47. Lansdowne AT, Provost SC. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology (Berl). 1998; 135: 319-323.
48. Dean AJ, Bellgrove MA, Hall T, et al. Effects of vitamin D supplementation on cognitive and emotional functioning in young adultsVa randomised controlled trial. PLoS One. 2011; 6: e25966.
49. Sanders KM, Stuart AL,Williamson EJ, et al. Annual high-dose vitamin D3 and mental well-being: randomised controlled trial. Br J Psychiatry. 2011; 198: 357-364.
50. Cass WA, Smith MP, Peters LE. Calcitriol protects against the dopamine-and serotonin-depleting effects of neurotoxic doses of methamphetamine. Ann N Y Acad Sci. 2006; 1074: 261-271.
51. Smith MP, Fletcher-Turner A, Yurek DM, et al. Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine. Neurochem Res. 2006; 31: 533-539.
52. Fernandes de Abreu DA, Eyles D, Feron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology. 2009; 34 (suppl 1): S265YS277.